vTv Therapeutics Inc. (VTVT) Stock News & Chart | StockAdder

(VTVT)

vTv Therapeutics Inc.

Stock chart and latest news for vTv Therapeutics Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

vTv Therapeutics Inc. News

PRO

vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements

Mar 17, 2026 simplywall.st

We Think vTv Therapeutics (NASDAQ:VTVT) Can Easily Afford To Drive Business Growth

Apr 6, 2026 Stock Titan

New vTv hire gets 4,000 stock options priced at $39.54

Apr 7, 2026 Seeking Alpha

VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst

Feb 28, 2026 GlobeNewswire

vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

Mar 10, 2026 MarketBeat

vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts

Mar 21, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF)

Mar 12, 2026 Yahoo Finance

Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade

Mar 17, 2026 Meyka

BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026

Mar 12, 2026 Sahm

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apr 8, 2026 GuruFocus

BTIG Initiates Coverage on vTv Therapeutics (VTVT) with a "Buy" Rating | VTVT Stock News

Nov 19, 2025 Stock Titan

Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv